The purpose of this study was to develop a radiopharmaceutical that could be used to selectively image 5-HT 1A receptors with positron emission tomography (PET). No-carrier-added 4-(28-methoxyphenyl)-1-[28-(N-29-pyridinyl)-p-[ 18 F]fluorobenzamido]ethylpiperazine ( p-[ 18 F]-MPPF, 2) was synthesized
Synthesis and in vivo evaluation of [18F]ORG 13063, a potential pet radioligand for the 5-HT1A receptor
✍ Scribed by M. Vandecapelle; F. De Vos; H. Vermeirsch; K. Strijckmans; D. Leysen; K. Audenaert; R. A. Dierckx; G. Slegers
- Book ID
- 112132878
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- French
- Weight
- 250 KB
- Volume
- 44
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract 4‐Fluoro‐__N__‐{2‐[4‐(6‐trifluoromethylpyridin‐2‐yl)piperazin‐1‐yl]ethyl}benzamide is a full 5‐HT~1A~ agonist with high affinity (__pK__~__i__~=9.3), selectivity and a __c__ log __P__ of 3.045. The corresponding PET radioligand 4‐[^18^F]fluoro‐__N__‐{2‐[4‐(6‐trifluoromethylpyridin‐2‐yl)
## Abstract This study evaluated the utility of __(S)‐N__‐[(1‐ethyl‐2‐pyrrolidinyl)methyl]‐5‐(3‐[^18^F]fluoropropyl)‐2,3‐dimethoxybenzamide ([^18^F]fluoropropylepidepride), [^18^F]5‐FPrEpid, as a ligar d for PET studies of cerebral dopamine D2 receptors. The in vitro affinity for the rat striatal d